More nations suspend AstraZeneca vaccine amid blood clot concerns
2021-03-17 00:00
The list is quickly growing of countries suspending the use of the COVID vaccine developed by AstraZeneca and the University of Oxford, following a number of cases in Europe of blood clots reported after the vaccine was administered.Germany, Italy, France and Spain were the latest.Germany announced on Monday a temporary halt in the use of the AstraZeneca vaccine as a precaution, according to Deutsche Welle, the German stateowned broadcaster, with Italy, France and Spain following suit later in the day.According to the German Health Ministry, the European Medicines Agency will decide whether and how the new information will affect the authorization of the vaccine, pending an investigation.After new reports of thromboses of the cerebral veins in connection with the vaccination in Germany and Europe, the PEI Paul Ehrlich Institute considers further investigations to be necessary, the German ministry announced in a statement. The PEI, which is near Frankfurt, is a federal agency and medical regulatory body.German Health Minister Jens Spahn said the risk of blood clots from the AstraZeneca inoculation is low, but could not be ruled out.Vaccine safety experts from the World Health Organization called an urgent meeting on Tuesday to review the OxfordAstraZeneca vaccine.The United Kingdoms medicines regulator and the WHO have said there is no evidence of a link, with the WHO recommending that countries continue vaccinating with AstraZeneca.WHO Chief Scientist Soumya Swaminathan told reporters on Monday that some blood clot incidents among the general population were to be expected.The European Medicines Agency also had a meeting on Tuesday and was expected to issue its decision on the continued use of the OxfordAstraZeneca vaccination on Thursday.The EMA currently remains of the view that the benefits of the AstraZeneca vaccine in preventing COVID  outweigh the risks of side effects, the agency said in a statement on Monday.Last week, Denmark became the first country to suspend implementation, with Norway, Iceland and Bulgaria following.The suspensions were not limited to Europe. Indonesia also announced a delay in its rollout of the AstraZeneca vaccine. Other nonEuropean nations that have suspended its use include Thailand and the Democratic Republic of Congo.Peter Kremsner, the director of the University of Tuebingen Hospital in Germany, told Deutsche Welle that blood clots pose a major health risk and the threat should be taken seriously by health authorities.AstraZenecas vaccine is one of the most widely used in the world. It makes up the bulk of the WHObacked COVAX facility, which aims to reduce inequities between highand lowincome countries in access to vaccines. More than  countries have authorized the vaccine.About  million people in the European Union and the UK have received a dose of the vaccine, with fewer than  cases of blood clots reported as of last week, AstraZeneca said.A careful review of all available safety data  has shown no evidence of an increased risk of pulmonary embolism, deep vein thrombosis or thrombocytopenia abnormally low platelet levels, in any defined age group, gender, batch or in any particular country, AstraZeneca said in a statement.It is not a good idea to stop an effective vaccine over theoretical concerns amid a continuing pandemic, Paul Offit, a vaccine expert at Childrens Hospital of Philadelphia, told Voice of America.There is nothing theoretical about this virus, which is killing thousands of people every day, he said. I would argue that the choice to just withhold that vaccine is not a conservative choice, but rather, a radical choice.Dirk Brockmann, an epidemiologist at The Robert Koch Institute in Berlin, told German broadcaster ARD on Tuesday that German coronavirus infections are spreading exponentially, up  percent in the past week.French officials have said the Paris region may be headed toward a new lockdown, as new COVID variants fill up hospitals intensive care wards and limited vaccine supplies drag down inoculation efforts, according to television network France .A study published in the journal Nature on Monday found that the B... variant, first identified in the UK last fall and by December was detected in several other countries, including the United States, is not only more transmissible, but more deadly than other coronavirus variants. The variant quickly took over as the dominant variant in the UK, late last year, sparking a damaging and deadly second wave.                                                                                                                                                                                                                                                          !CDATA            function shareweixin              var ua  navigator.userAgent.toLowerCase              ifiphoneipadipod.testua  ua.matchMicroMessengeri  micromessenger                window.opena.app.qq.comosimple.jsp?pkgnamecom.theotino.chinadailyiosschemeencodeIos                            else ifandroid.testua  ua.matchMicroMessengeri  micromessenger                window.opena.app.qq.comosimple.jsp?pkgnamecom.theotino.chinadailyandroidschemeencodeAndroid                            else                window.openwww.chinadaily.com.cnmobiledaily.html